Recent clinical trials show benefits for weight loss and lowering glucose in this population
The medications ability to help patients achieve and maintain a healthier weight can have profound effects on their overall well-being, reducing the risk of serious health conditions associated with obesity
Oral supplements are available, but they may have lower bioavailability compared to IV administration
It oxidizes a broad range of important clinical drugs that fall under the categories of nonsteroidal anti-inflammatory agents
Oxidative stress takes place when the body has too many free radicals, or unstable molecules, that damage cells
GLP-1 Agonists as a Complementary Tool : In contrast, while GLP-1 agonists can aid in reducing body weight and improving health markers, they are less likely to produce the transformative weight loss that is often necessary for significant disease resolution in morbidly obese patients